Rocket Pharmaceuticals Inc

RCKTNASDAQ · USD
2.60USD0.00 (-3.54%)
137

Rocket Pharmaceuticals Inc (RCKT) Straddle

RCKT straddle scan found 4 qualifying long straddle setups on the previous trading day. Probability of profit reaches up to 42.7%.

Read more

Trading a RCKT straddle lets you take a pure volatility position on Rocket Pharmaceuticals Inc without committing to a direction. Rocket Pharmaceuticals Inc's straddle involves buying (or selling) a call and a put at the same strike and expiration, profiting when the stock moves more (or less) than the combined premium implies. Use our scanner to evaluate RCKT straddle pricing in real time and find the moments when expected moves are mispriced.

A long straddle on RCKT profits from large moves in either direction and is a classic play into binary events like earnings, product announcements, or macro releases. A short straddle profits when Rocket Pharmaceuticals Inc stays range-bound and implied volatility contracts. The breakeven points are simple: strike plus total premium on the upside, strike minus total premium on the downside. Comparing the RCKT straddle price to historical realized moves helps you judge whether the market is overpaying or underpaying for volatility.

Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells or promotes the production of faulty blood cells; leukocyte adhesion deficiency-I, a genetic disorder that causes the immune system to malfunction; and pyruvate kinase deficiency, a rare red blood cell autosomal recessive disorder that results in chronic non-spherocytic hemolytic anemia.

The company also has a clinical stage in vivo adeno-associated virus program for Danon disease, a multi-organ lysosomal-associated disorder leading to early death due to heart failure. It has license agreements with Fred Hutchinson Cancer Research Center; Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas (CIEMAT), Centro de Investigacion Biomedica En Red, and Fundacion Instituto de investigacion Sanitaria Fundacion Jimenez Diaz; CIEMAT and UCL Business PLC; The Regents of the University of California; and REGENXBIO, Inc. Rocket Pharmaceuticals, Inc. is headquartered in Cranbury, New Jersey.

Earnings, product cycles, macro prints — any time volatility itself is the trade, the RCKT straddle is the cleanest expression of that view. Our scanner prices every RCKT straddle against historical realized moves, flags expirations where the market is overpaying or underpaying for vol, and ranks setups by breakeven width and IV rank. Whether you're long a RCKT straddle into a catalyst or short a RCKT straddle to harvest decay, the options straddle setups that matter are all in one place.

Apr 16, 20277.50$4.602051%42.7%$12.10$2.901
Jan 15, 20277.50$4.681141%34.0%$12.18$2.8321
Apr 16, 20275.00$2.582051%15.5%$7.58$2.4340
Nov 20, 20265.00$2.43581%8.2%$7.43$2.580

As of September 25, 2026

Find the right straddle before volatility moves

Track RCKT straddle pricing across expirations, filter by IV rank and breakeven points, and build a setup that fits your view before the move happens.

Start your 14-day free trial